Thrombin plays several roles in coagulation. It has been an attractive target for rational drug design efforts. There are two major inhibitor binding sites. The active site is the obvious one, but X-ray crystallography showed that the leech anticoagulant hirudin binds to another region called the exosite.
This crystal structure shows thrombin (activated by cleavage into heavy & light chains) with hirugen bound into the exosite and another inhibitor bound into the active site.